A Single Center Experience of Super-Responders Among Severe Asthma Patients Receiving Treatment with Mepolizumab
(Thorac Res Pract 2022; 23: 348-354) DOI: 10.5152/TurkThoracJ.2022.22023
(Thorac Res Pract 2022; 23: 348-354) DOI: 10.5152/TurkThoracJ.2022.22023